$ILMN
Illumina, Inc.
Nasdaq · Technology · Laboratory Analytical Instruments · San Diego, CA
ILMN chart
What traders are saying about $ILMN
Latest postsIllumina, Inc. news
- Illumina at UBS Global Healthcare Conference: clinical demand drives growth By Investing.com
Investing.com UK ·
- Nucleic Acid Isolation and Purification - Global Strategic Business Report: Capture the $3.9 Billion Revenue Surge by 2030 as Thermo Fisher, Qiagen, Danaher, Illumina, and Bio-Rad Battle for Share
Yahoo Finance ·
- Gene Panels - Global Strategic Business Report 2026: Capitalize on 17.9% CAGR as Market Triples to $12.6B by 2032 - Track Key Players Illumina, Roche, QIAGEN, Thermo Fisher, Agilent and More
Yahoo Finance ·
- Global DNA and Genomic Profiling Kits Market Report 2026 | Capture the $2.09B Market by 2030 | Features Profiles of Thermo Fisher, Illumina, QIAGEN and More
Yahoo Finance ·
- Investors Shouldn't Be Too Comfortable With Illumina's (NASDAQ:ILMN) Earnings
Simply Wall St ·
- Illumina updates Clarity LIMS with expanded sequencing support and workflow improvements
Scientific Computing World ·
- Form 4 Illumina Inc: Patricia Leckman (SVP, Chief People Officer) For: 5 November
Investing.com UK ·
- Illumina Inc. stock outperforms competitors on strong trading day
MarketWatch ·
- 360 Illumina (ILMN) shares were delivered or withheld for exercise price or tax liability.
Stock Titan ·
- 150 shares were delivered or withheld at $208 each for Illumina (ILMN) officer Scott D. Ericksen.
Stock Titan ·
- 208 shares at $208 each were delivered or withheld by Illumina (ILMN) Chief People Officer Leckman.
Stock Titan ·
- 604 shares were delivered or withheld for exercise price or taxes by Illumina (ILMN)'s operations chief.
Stock Titan ·
Illumina, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $4.34B | $4.37B | $4.50B | $4.58B |
| Net income | $850.0M | -$1.22B | -$1.16B | -$4.40B |
| Diluted EPS | $5.45 | $-7.69 | $-7.34 | $-28.00 |
| Total assets (year end) | $6.64B | $6.30B | $10.11B | $12.25B |
| Cash and equivalents (year end) | – | – | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Illumina, Inc.
- Ticker
- ILMN (Nasdaq)
- Industry
- Laboratory Analytical Instruments
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- January 3
- SEC CIK
- 1110803
- Former names
- ILLUMINA INC
Frequently asked questions
What exchange is Illumina, Inc. listed on?
Illumina, Inc. trades on the Nasdaq under the ticker symbol ILMN.
What industry is Illumina, Inc. in?
Illumina, Inc. is classified by the SEC under "Laboratory Analytical Instruments", part of the Technology sector on StockTweeting.
Where is Illumina, Inc. headquartered?
Illumina, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Illumina, Inc.'s fiscal year end?
Illumina, Inc.'s fiscal year ends on January 3.
How much revenue did Illumina, Inc. report?
Illumina, Inc. reported $4.34B in revenue for calendar year 2025, according to its SEC filings.